Debora A. Paterniti, Ph.D.
Conversations About Treatment at the End of Life. Rich BA, Paterniti DA. J Gen Intern Med. 2011 Mar 30. [Epub ahead of print] No abstract available.
Relational barriers to depression help-seeking in primary care. Kravitz RL, Paterniti DA, Epstein RM, Rochlen AB, Bell RA, Cipri C, Fernandez y Garcia E, Feldman MD, Duberstein P. Patient Educ Couns. 2011 Feb;82(2):207-13. Epub 2010 Jun 8.
"I didn't know what was wrong:" how people with undiagnosed depression recognize, name and explain their distress. Epstein RM, Duberstein PR, Feldman MD, Rochlen AB, Bell RA, Kravitz RL, Cipri C, Becker JD, Bamonti PM, Paterniti DA. J Gen Intern Med. 2010 Sep;25(9):954-61. Epub 2010 May 15.
Successful self-directed lifelong learning in medicine: a conceptual model derived from qualitative analysis of a national survey of pediatric residents. Li ST, Paterniti DA, Co JP, West DC. Acad Med. 2010 Jul;85(7):1229-36
Barriers in Diagnosing and Treating Men With Depression: A Focus Group Report. Rochlen AB, Paterniti DA, Epstein RM, Duberstein P, Willeford L, Kravitz RL. Am J Mens Health. 2009 May 11. [Epub ahead of print]
Community-based advocacy training: applying asset-based community development in resident education. Hufford L, West DC, Paterniti DA, Pan RJ. Acad Med. 2009 Jun;84(6):765-70.
Marketing therapeutic precision: Potential facilitators and barriers to adoption of n-of-1 trials. Kravitz RL, Paterniti DA, Hay MC, Subramanian S, Dean DE, Weisner T, Vohra S, Duan N. Contemp Clin Trials. 2009 Apr 16. [Epub ahead of print]
Burnout assessment in house officers: evaluation of an intervention to reduce stress. Milstein JM, Raingruber BJ, Bennett SH, Kon AA, Winn CA, Paterniti DA. Med Teach. 2009 Apr;31(4):375-8.
Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives. Tarn DM, Paterniti DA, Williams BR, Cipri CS, Wenger NS. J Am Geriatr Soc. 2009 Mar;57(3):462-9. Epub 2009 Jan 17.
Discussing Depression with Vietnamese American Patients. Fancher TL, Ton H, Le Meyer O, Ho T, Paterniti DA. J Immigr Minor Health. 2009 Feb 26. [Epub ahead of print]
Does poorer familiarity with Medicare translate into worse access to health care? Morgan RO, Teal CR, Hasche JC, Petersen LA, Byrne MM, Paterniti DA, Virnig BA. Journal of the American Geriatrics Society. 2008 Nov;56(11):2053-60.
How much time does it take to prescribe a new medication? Tarn DM, Paterniti DA, Kravitz RL, Heritage J, Liu H, Kim S, Wenger NS. Patient Education and Counseling. 2008 Aug;72(2):311-9. 2008 Apr 10; [Epub ahead of print]
Overcoming barriers to cancer clinical trial accrual: Impact of a mass media campaign. Umutyan A, Chiechi C, Beckett LA, Paterniti DA, Turrell C, Gandara DR, Davis SW, Wun T, Chen MS Jr, Lara PN Jr. Cancer. 2008 Jan 1;112(1):212-9
Factors Affecting Physicians’ Responses to Patients’ Requests for Antidepressants: Focus Group Study. Vanderveen KA, Tentler A, Silberman J, Paterniti DA, Kravitz RL, Epstein RM. J Gen Intern Med. 2008 Jan;23(1):51-7. Epub 2007 Nov 7.
Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Vanderveen KA, Paterniti DA, Kravitz RL, Bold RJ. Ann Surg Oncol. 2007 May;14(5):1662-9. Epub 2007 Feb 7.
From Physician-Centered to Community-Oriented Perspectives on Health Care: Assessing the Efficacy of Community-based Training. Paterniti DA, Pan R J, Smith LF, Horan NM, West DC.Academic Medicine. 2006 March;81:347-353.
Medicare Beneficiary Knowledge: Measurement Implications from a Qualitative Study. Teal CR, Paterniti DA, Murphy CL, John DA, Morgan, RO. Health Care Financing Review. 2006 Summer;27(4):13-23.
Physician Communication When Prescribing New Medications. Derjung MT, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Archives of Internal Medicine. 2006;166:1855-82.
Asian Americans and Cancer Clinical Trials: A mixed methods approach to understanding awareness and experience. Paterniti DA, Chen MS, Chiechi C, Beckett LA, Horan N, Turrell C, Smith L, Morain C, Montell L, Gonzalez J, Davis S, Lara PN. Cancer. 2005;104(12Suppl):3015-24.
Tamoxifen for Breast Cancer Risk Reduction: Women's Perspectives
Paterniti DA, Melnikow J, Nuovo J, Henderson S, DeGregorio M, Kuppermann N, Nease R
Ethnicity and Disease. 15(3):365-372. Summer.
An Approach to Stimulate Effective Decision-Making in Medical Treatment, Advanced Care Planning, and End-of-Life Care for Women in Prison
Enders SR, Paterniti DA, Meyers FJ
Journal of Palliative Medicine. 8(2):432-439
Preferences of Women Evaluating Risks (P.O.W.E.R.) Study of Tamoxifen for Breast Cancer Risk Reduction
Melnikow J, Paterniti DA, Azari R, Kuenneth C, Birch S, Kuppermann M, Nuovo J, Keyzer J, Hendersen S
Cancer. 103:1996-2005. May